Wattignies, France

Ingrid Dufour

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Genfit. Active years: 2014-2020.

USPTO Granted Patents = 8 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Genius of Ingrid Dufour

Introduction

Ingrid Dufour, an accomplished inventor based in Wattignies, France, has made significant contributions to the field of pharmaceutical innovations. With a total of 8 patents to her name, Dufour has focused her efforts on developing therapeutic solutions that address critical health issues, particularly those related to liver disorders.

Latest Patents

Dufour's most recent patents include pioneering work on the use of 1,3-diphenylprop-2-en-1-one derivatives for the treatment of liver disorders. This groundbreaking invention outlines the development of pharmaceutical formulations that significantly reduce the plasma levels of harmful biochemical markers such as aminotransferases. The 1,3-diphenylprop-2-en-1-one derivatives, recognized for their hepatoprotective properties, offer new methods for treating liver conditions that involve disruption, inflammation, degeneration, or proliferation of liver cells, including complex issues like liver fibrosis and fatty liver disease.

Career Highlights

Ingrid Dufour has established herself as a leading figure within her industry through her relentless pursuit of innovation. Her work at Genfit, a company dedicated to developing therapeutic solutions, showcases her expertise and commitment to improving liver health. Dufour's contributions extend beyond her patents; she exemplifies the spirit of research and its impact on real-world medical challenges.

Collaborations

Throughout her career, Dufour has had the advantage of collaborating with talented colleagues, including Raphael Darteil and Rémy Hanf. These partnerships have fostered an environment of creativity, leading to productive research initiatives that enhance the potential for groundbreaking discoveries in the field of liver disease treatment.

Conclusion

Ingrid Dufour represents the forefront of innovation in pharmaceutical research, with her work promising significant advancements in the treatment of liver disorders. With her impressive slate of patents and valuable collaborations, Dufour continues to pave the way for future research and development efforts, ensuring that her contributions will have a lasting impact on healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…